Summit Cancer Center

Spokane, Washington 99208

1 studies enrolling now · 5 studies all time

What they study most

Bladder Cancer, Carcinoma, Transitional Cell, Endometrial Adenocarcinoma, Head and Neck Squamous Cell Carcinoma, Hodgkin Lymphoma, Malignant Melanoma, Melanoma, Metastatic Colorectal Cancer (mCRC), Non Small Cell Lung Cancer, Oncology, Renal Cell Carcinoma, Solid Tumor

Studies at this site

• A Phase 1 of CTX-8371 in Patients With Advanced Malignancies — Recruiting now
• A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma — Recruiting now
• The Phase-2 CCR5-targeting Leronlimab With Oral Chemotherapy and VEGF-inhibitor Enriched Regimen Trial (CLOVER) — Running, not enrolling
• Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors — Stopped early
• Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma — Completed